IL133612A0 - Formulations containing estramustine phosphate and albumin - Google Patents

Formulations containing estramustine phosphate and albumin

Info

Publication number
IL133612A0
IL133612A0 IL13361299A IL13361299A IL133612A0 IL 133612 A0 IL133612 A0 IL 133612A0 IL 13361299 A IL13361299 A IL 13361299A IL 13361299 A IL13361299 A IL 13361299A IL 133612 A0 IL133612 A0 IL 133612A0
Authority
IL
Israel
Prior art keywords
albumin
formulations containing
estramustine phosphate
containing estramustine
phosphate
Prior art date
Application number
IL13361299A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IL133612A0 publication Critical patent/IL133612A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13361299A 1998-03-27 1999-03-26 Formulations containing estramustine phosphate and albumin IL133612A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7954298P 1998-03-27 1998-03-27
PCT/US1999/004275 WO1999049869A1 (en) 1998-03-27 1999-03-26 Methods to potentiate intravenous estramustine phosphate

Publications (1)

Publication Number Publication Date
IL133612A0 true IL133612A0 (en) 2001-04-30

Family

ID=22151209

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13361299A IL133612A0 (en) 1998-03-27 1999-03-26 Formulations containing estramustine phosphate and albumin

Country Status (16)

Country Link
EP (1) EP1003521A4 (ja)
JP (1) JP2001508810A (ja)
KR (1) KR20010021656A (ja)
CN (2) CN1273530A (ja)
AU (1) AU750010B2 (ja)
BR (1) BR9906425A (ja)
CA (1) CA2295049A1 (ja)
EA (1) EA004647B1 (ja)
HU (1) HUP0200547A3 (ja)
ID (1) ID24504A (ja)
IL (1) IL133612A0 (ja)
NO (1) NO20002343L (ja)
NZ (1) NZ501987A (ja)
PL (1) PL342969A1 (ja)
WO (1) WO1999049869A1 (ja)
ZA (1) ZA997821B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003201D0 (en) * 2000-02-11 2000-04-05 Pharmacia & Upjohn Spa Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
US6436913B1 (en) * 2000-07-25 2002-08-20 Pharmacia & Upjohn Company Use of estramustine phosphate in the treatment of bone metastasis
RU2471511C1 (ru) * 2011-05-04 2013-01-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) Способ лечения метастазов в печень рака толстой кишки

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617292A (ja) * 1984-06-20 1986-01-13 Japan Atom Energy Res Inst 制癌剤を結合させたエストラサイト系化合物を製造する方法
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
ATE194767T1 (de) * 1992-03-23 2000-08-15 Univ Georgetown In liposomen verkapseltes taxol und verwendungsverfahren
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.

Also Published As

Publication number Publication date
CN1636598A (zh) 2005-07-13
AU750010B2 (en) 2002-07-11
EP1003521A1 (en) 2000-05-31
JP2001508810A (ja) 2001-07-03
ZA997821B (en) 2000-08-01
EP1003521A4 (en) 2003-07-23
NZ501987A (en) 2002-10-25
CA2295049A1 (en) 1999-10-07
BR9906425A (pt) 2000-07-11
HUP0200547A3 (en) 2003-07-28
NO20002343D0 (no) 2000-05-04
AU3353399A (en) 1999-10-18
EA004647B1 (ru) 2004-06-24
NO20002343L (no) 2000-05-04
HUP0200547A2 (hu) 2002-07-29
KR20010021656A (ko) 2001-03-15
EA199901081A1 (ru) 2000-12-25
CN1273530A (zh) 2000-11-15
ID24504A (id) 2000-07-20
WO1999049869A1 (en) 1999-10-07
PL342969A1 (en) 2001-07-16

Similar Documents

Publication Publication Date Title
HUP0103267A2 (hu) Glifozát-tartalmú készítmények és alkalmazásuk
SG114454A1 (en) Laser dermablator and dermablation
GB9715751D0 (en) Formulations
IL131742A0 (en) Oxyalkylene phosphate compounds and uses thereof
AU4208799A (en) Interleukins-21 and 22
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
PL346423A1 (en) Microcapsule formulations
PL346414A1 (en) Microcapsule formulations
GB2326882B (en) Gelling agents comprising aluminum phosphate compounds
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
IL136612A0 (en) Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same
HUP0000125A3 (en) Liquid alendronate formulations and producing them
IL143470A0 (en) Organophosphorus compounds and use thereof
IL133612A0 (en) Formulations containing estramustine phosphate and albumin
ZA9810773B (en) Revitalisation formulation
AU6328799A (en) Organophosphorous compounds and use thereof
IL147745A0 (en) Formulations for parenteral use of estramustine phosphate and albumin
GB9921958D0 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
GB9706957D0 (en) Formulation
EP0998578A4 (en) SEL-10 AND USES OF SEL-10
GB9918779D0 (en) Formulations for parenteral use of estramustine phosphate and albumin
IL134499A0 (en) Pyrimidin-2- oxy-4-one and pyrimidin-2-oxy- 4-thione derivatives
GB9803809D0 (en) The strimmer and rotovar adaptor

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees